COVID-19, a coronavirus first detected in Wuhan in December 2019, has now spread rapidly to over 30 countries infecting more than 70000 persons. The largest study to date found that out of 44672 confirmed cases registered in China's Infectious Disease Information System up to 11 February 2020, there were 416 (0.9%) between the ages of 0-9 years and 549 (1.2%) between the ages of 10-19 years ([@bib0015]). There was one reported death in the category of 10-19 years. This seemed to indicate that the number of children infected was much less and their prognosis better compared with the adults. However, there is limited literature on COVID-19 in children.

We report 4 confirmed cases in children that were diagnosed and treated in Malaysia. The cases ranged from 20 months to 11 years of age \[[Table 1](#tbl0005){ref-type="table"} \]. All four cases were likely to have contracted the virus in China. Of these, only one was a Malaysian who had visited Wuhan for the Chinese New Year festival as his mother originated from Wuhan. The patients were mostly asymptomatic or had mild symptoms. Case 1 was asymptomatic until day 17 when fever and diarrhoea occurred. Nevertheless, the child's swabs were negative at that time. Case 2 had intermittent fever and upper respiratory tract symptoms. Case 3 was asymptomatic throughout. Case 4 had a mild cough and wheeze that responded well to salbutamol inhaler. None of the children required treatment with anti-virals. It is unknown why children with COVID-19 appeared to have milder disease. The adults may be more susceptible due to pre-existing conditions such as hypertension, diabetes, heart disease or smoking which could weaken their ability to ward off infections. The adults may also be more susceptible to an immune overdrive that leads to acute respiratory distress syndrome (ARDS). The mild or asymptomatic presentation in children may have impacted on infection control as they could be missed by existing surveillance. Further research needs to be carried out on the paediatric population to explore this matter.Table 1Demographic and Clinical data.Table 1Case 1Case 2Case 3Case 4Age20 months4 years9 years11 yearsGenderMaleFemaleMaleMaleEthnicityChineseChineseChineseChineseNationalityChinaChinaMalaysiaChinaMethod of detectionContact tracingSelf-presentationScreening for Wuhan evacueeContact tracingDate of infectionLeft Wuhan on 20 January 2020Left Foshan on 19 January 2020.Left Wuhan on 4 February 2020Left Wuhan on 20 January 2020Date of detection24 January 202026 January 20204 February 202024 January 2020Date of confirmation25 January 202026 January 20204 February 202025 January 2020Site of detectionHotel, JohorEmergency Dept, HospitalKuala Lumpur International AirportHotel, JohorSite of treatmentHospital Sungai BulohHospital Sultanah Maliha, LangkawiHospital SerembanHospital Sungai BulohSymptomsAsymptomatic until D17 when he developed mild fever and diarrhoeaRunny nose and cough for 2-4 weeks, intermittent fever between 25- 30 JanuaryAsymptomaticMild cough for one day. Later diagnosed clinically as asthmaMethod of diagnosisNasopharyngeal and throat swabs taken for PCRNasal swabs taken for PCRNasopharyngeal and throat swabs taken for PCRNasopharyngeal and throat swabs taken for PCRSwabs negative on10, 11 and 12 February 20201 and 3 February 202013 and 17 February 202010, 11 and 12 February 2020Other investigationsRenal and liver profile normal. Rectal swab negative for COVID-19Blood culture showed no growth. No other investigations. Nasal swab also positive for influenza AChest X- ray showed right perihilar opacitiesChest X- ray showed perihilar opacitiesTreatmentParacetamol and Oral Rehydration SaltsParacetamol, oral penicillin V, loratadineNoneMDI salbutamol prnQuarantine precautionsQuarantined with family in non-negative pressure roomQuarantined with younger sibling and parents in negative pressure roomQuarantined with father in negative pressure roomQuarantined with family in non-negative pressure roomPPE for staffPPE for staffPPE for staffPPE for staff

There were issues regarding the care of paediatric cases that should be highlighted. Firstly, should an infected child under quarantine be separated from parents who were tested negative? Case 1 and Case 4 were brothers who were quarantined with their grandmother who was tested positive and their mother who was initially tested negative but later tested positive. The mother was advised regarding the high risk of being infected but she insisted on being quarantined together with her mother in law and children. Even though the patients were given masks, they may not have fully complied with the proper protocol. Case 2 was quarantined together with a younger sibling and parents who were well and had negative swabs for COVID-19 throughout their stay. The CDC guidance for the prevention and control of influenza in the peri- and post-partum settings recommends temporary separation of an ill mother and her child ([@bib0005]). However, this separation may lead to a negative impact on both the child and the mother. The CDC states that the risks and benefits should be discussed with the mother and decisions made in accordance with the mother's wishes.

Secondly, there are difficulties to obtain respiratory samples from paediatric patients. The 20-month-old child vomited on the doctor during the blood taking procedure. Performing throat and nasopharyngeal swabs are technically more difficult in paediatric patient and may sometimes require more than one healthcare provider to be fully gowned up in the room to assist the procedure. The Malaysian protocol states that the cases would be considered negative if two consecutive swabs are negative. However, some of the throat and nasopharyngeal swabs that were positive in Case 1 and Case 4 turned negative in testing and later reverted to positive \[[Table 2](#tbl0010){ref-type="table"} \]. The early negative results were likely false negatives from sampling error due to difficulty in obtaining respiratory specimens from this age group. It may be necessary to have three consecutive negative swabs before considering the patient to be fully recovered. The RT-PCR cycle threshold \[CT} value gives an estimate of the viral load where the lower the CT value, the higher the viral load ([@bib0020]). However, the relationship between viral load and disease severity is still uncertain and under research. Presently RT-PCR Ct values are not used in the clinical management of COVID-19.Table 2Swab results.Table 2Case 1Case 2Case 3Case 4OPSNPSOPSNPSOPSNPSOPSNPS123 Jan Positive23 Jan Positive26 Jan Positive26 Jan Positive [\*](#tblfn0005){ref-type="table-fn"}28.014 Feb Positive4 Feb Positive23 Jan Positive23 Jan Positive25 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}31.55 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}31.041 Feb Negative1 Feb Negative7 Feb Positive7 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}32.055 Feb Negative5 Feb Negative38 Feb Negative8 Feb Negative3 Feb Negative3 Feb Negative10 Feb Positive10 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}35.648 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}40.648 Feb Negative49 Feb Negative9 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}39.9713 Feb Negative13 Feb Negative9 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}39.059 Feb Negative510 Feb Negative10 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}37.5517 Feb Negative17 Feb Negative10 Feb Negative10 Feb Positive [\*](#tblfn0005){ref-type="table-fn"}36.42611 Feb Negative11 Feb Negative11 Feb Negative11 Feb Negative712 Feb Negative12 Feb Negative12 Feb Negative12 Feb Negative[^1]

There has been an expert consensus statement from China on the diagnosis, treatment and prevention of COVID-19 on the 7th of February 2020 ([@bib0010]). Most of the measures taken in these 4 cases agreed with the statement except for traditional treatments that were not used in our hospitals. We aimed to share the findings of the 4 cases in order to highlight the relatively mild symptoms of COVID-19 in children and the difficulties encountered in the care of paediatric patient affected by the illness.
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[^1]: RT-PCR Ct Value, OPS : oropharyngeal swab, NPS : nasopharyngeal swab
